Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113980017A reveals a high-yield asymmetric hydrogenation route for tetrahydro-13-methyl berberine derivatives, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Novel copper-catalyzed route for pyrone[3,4-b]indole derivatives. Reduces cost, simplifies scale-up for pharma intermediates.
Advanced synthesis method for high-purity deuterated celecoxib intermediate offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Novel synthesis method for NR chloride using TMSOTf activation. Reduces cost and improves purity for pharmaceutical intermediates manufacturing.
Novel Rh-catalyzed one-pot synthesis for 1,9-diazaphenalene derivatives. High yield, scalable process for OLED and pharma intermediates.
Patent CN101941971B details a green synthesis of Evodiamine via catalytic hydrogenation and anhydride condensation, offering high purity and cost reduction for pharma manufacturing.
Patent CN106220586A details a metal-free synthesis of 5-amino-1,2,4-selenadiazole derivatives using selenium powder, offering high yields and supply chain reliability for pharmaceutical intermediates.
Patent CN110407739B details a high-yield, one-pot synthesis of diaryl-tetrahydropyridines. This method offers 100% atom economy and mild conditions for reliable pharmaceutical intermediate supply.
Patent CN106467481A enables green synthesis of indole-3-aryl ketones. Visible light catalysis reduces costs and ensures reliable pharmaceutical intermediates supplier continuity.
Novel tertiary amine-thiourea catalyst enables high-yield asymmetric conjugate addition for scalable API intermediate production with superior enantioselectivity.
Patent CN110330460B details a high-yield solid acid catalyzed route for p-hydroxyphenylhydantoin, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Novel Pd-catalyzed method offers high yield and enantioselectivity for chiral intermediates. Reduces costs and simplifies supply chain for pharmaceutical manufacturing partners globally.
Novel synthesis route offers high yield and mild conditions for pharmaceutical intermediates, ensuring supply chain stability and cost efficiency for global buyers.
Novel Grignard route for Lasmiditan precursors offering high yield and reduced waste for reliable API manufacturing supply chains.
Patent CN107739322B details a novel Ir-catalyzed C-H activation route for sulfonamides. Discover cost-effective, high-yield manufacturing solutions for pharma and agrochemical intermediates.
Patent CN109251192A details Ir-catalyzed synthesis of trifluoromethyl isocoumarins. Offers high purity, mild conditions, and scalable supply chain solutions for pharmaceutical intermediates.
Advanced refining patent CN115594643B ensures high purity triazole intermediates. Significant cost reduction and supply chain reliability for global pharmaceutical manufacturing partners.
Novel patent CN107382897A enables high-purity Betrixaban intermediate production with reduced waste and enhanced supply chain reliability for global pharmaceutical manufacturers.
Patent CN103189352A reveals a novel organocatalytic Mannich reaction for high-purity pharmaceutical intermediates, offering significant cost reduction and scalable supply chain solutions.
Discover a novel Brivaracetam synthesis method avoiding chiral columns. Enhanced purity, reduced costs, and scalable manufacturing for pharmaceutical intermediates.